ARS Pharmaceuticals (SPRY) Gross Margin (2024 - 2026)
ARS Pharmaceuticals (SPRY) reported Gross Margin of 61.83% for Q2 2026, down 6.46 percentage points from 68.29% a year earlier and down 10.45 percentage points from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Gross Margin (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, ARS Pharmaceuticals' Gross Margin came in at 71.37%, down 22.35 percentage points year-over-year; for FY2025, it came in at 75.77%, down 23.14 percentage points from FY2024.
- By year, Gross Margin came in at 98.90% in FY2024 (-1.10 pp) and 100.00% in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Gross Margin in data going back to Q2 2024.
- Year over year, Gross Margin has now declined in each of the last five quarters, with an average year-over-year change of -18.57 percentage points over the last five quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at 72.29% (Q1 2026), 78.09% (Q4 2025) and 74.80% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | 61.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.83% |
| Mar 31, 2026 | 72.29% |
| Dec 31, 2025 | 78.09% |
| Sep 30, 2025 | 74.80% |
| Jun 30, 2025 | 68.29% |
| Mar 31, 2025 | 86.28% |
| Dec 31, 2024 | 99.00% |
| Sep 30, 2024 | 94.58% |
| Jun 30, 2024 | 100.00% |
API Access
ARS Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();